TGFB1 and lymphoma: Foster et al. [31] used a clinical grade retrovirus vector to construct dnTGF-βRII-expressing human antigen-specific cytotoxic T lymphocytes (CTLs) and found that TGF-β-resistant CTLs had a functional advantage over unmodified CTLs in the TGF-β-secreting lymphoma [31].